<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Capsaicin</id>
	<title>Capsaicin - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Capsaicin"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Capsaicin&amp;action=history"/>
	<updated>2026-04-18T12:07:38Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Capsaicin&amp;diff=229820&amp;oldid=prev</id>
		<title>ClaireLewis: Created page with &quot;==Administration== *Type: Topical analgesic *Dosage Forms: *Routes of Administration: Topical *Common Trade Names:   ==Adult Dosing== *Apply to affected area TID or QID  ==Ped...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Capsaicin&amp;diff=229820&amp;oldid=prev"/>
		<updated>2019-09-24T03:34:29Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;==Administration== *Type: Topical analgesic *Dosage Forms: *Routes of Administration: Topical *Common Trade Names:   ==Adult Dosing== *Apply to affected area TID or QID  ==Ped...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Administration==&lt;br /&gt;
*Type: Topical analgesic&lt;br /&gt;
*Dosage Forms:&lt;br /&gt;
*Routes of Administration: Topical&lt;br /&gt;
*Common Trade Names: &lt;br /&gt;
&lt;br /&gt;
==Adult Dosing==&lt;br /&gt;
*Apply to affected area TID or QID&lt;br /&gt;
&lt;br /&gt;
==Pediatric Dosing==&lt;br /&gt;
''Not approved for pediatric use''&lt;br /&gt;
&lt;br /&gt;
==Special Populations==&lt;br /&gt;
===[[Drug pregnancy categories|Pregnancy Rating]]===&lt;br /&gt;
*Category B&lt;br /&gt;
&lt;br /&gt;
===Lactation risk===&lt;br /&gt;
*Unknown if absorbed and excreted in milk. DO NOT apply to nipple!&lt;br /&gt;
&lt;br /&gt;
===Renal Dosing===&lt;br /&gt;
*Not established&lt;br /&gt;
===Hepatic Dosing===&lt;br /&gt;
*Not established&lt;br /&gt;
&lt;br /&gt;
==Contraindications==&lt;br /&gt;
*Allergy to class/drug&lt;br /&gt;
*Application to broken or infected skin&lt;br /&gt;
&lt;br /&gt;
==Adverse Reactions==&lt;br /&gt;
===Serious===&lt;br /&gt;
&lt;br /&gt;
===Common===&lt;br /&gt;
*Transient increased pain at application site (dissipates w/ continued use)&lt;br /&gt;
*Application site erythema&lt;br /&gt;
*Pain&lt;br /&gt;
*Nausea/vomiting&lt;br /&gt;
*Rash, dryness pruritus, edema, exfoliation, skin odor&lt;br /&gt;
*Hypertension&lt;br /&gt;
*Sinusitis, bronchitis, cough&lt;br /&gt;
*Dizziness, Headache&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
*Half-life: &lt;br /&gt;
*Metabolism: &lt;br /&gt;
*Excretion: &lt;br /&gt;
&lt;br /&gt;
==Mechanism of Action==&lt;br /&gt;
* &amp;quot;Transient receptor potential vanilloid-1 (TRPV1) agonist; topical application causes initial TRPV1 stimulation that may cause pain, followed by pain relief by reduction in TRPV1-expressing nociceptive nerve endings&amp;quot;&amp;lt;ref&amp;gt;https://reference.medscape.com/drug/capzasin-p-zostrix-capsaicin-topical-999316#10&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Comments==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Pharmacology]]&lt;/div&gt;</summary>
		<author><name>ClaireLewis</name></author>
	</entry>
</feed>